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Abstrak 
Ibu yang melahirkan dengan operasi caesar (SC) seringkali mengalami kesulitan untuk 
mendapatkan produksi ASI yang memadai. Berbagai upaya telah dilakukan untuk 
mengatasi masalah tersebut, termasuk intervensi farmakologis. Salah satu obat yang 
mungkin digunakan adalah domperidon. Domperidon merupakan reseptor antagonis 
dopamin perifer yang bekerja dengan cara menghambat efek penghambatan sekresi 
prolaktin yang difasilitasi oleh dopamin untuk meningkatkan produksi ASI. Penelitian 
ini bertujuan untuk mengungkap pengaruh domperidon terhadap produksi ASI pada ibu 
melahirkan dengan SC di Indonesia. Penelitian ini merupakan penelitian eksperimen 
semu dengan desain two group post test only. Sampel dalam penelitian ini adalah 30 
pasien post sectio caesarea yang terdiri dari 15 pasien kelompok intervensi dan 15 pasien 
kelompok kontrol. Pengambilan sampel dilakukan dengan purposive sampling. Instrumen 
yang digunakan adalah lembar observasi. Analisis hasil dilakukan dengan menghitung 
distribusi frekuensi dan analisis bivariat dengan uji Mann Whitney. Rata-rata skor produksi 
ASI pada ibu pasca SC pada kelompok intervensi adalah 22,60, sedangkan skor rata-rata 
produksi ASI pada ibu post SC pada kelompok kontrol adalah 15,47, Asymp. nilai Sig (2 
tailed) 0,020 (0,020 <0,05). Domperidone telah disetujui memiliki pengaruh yang signifikan 
untuk meningkatkan produksi ASI pada ibu pasca SC. Peningkatan produksi ASI dapat 
dilakukan secara non-farmakologis, tetapi terapi farmakologis juga dapat dipertimbangkan 
jika terapi nonfarmakologis tidak bekerja dengan baik dalam meningkatkan produksi ASI.
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Abstract 
Mothers that give birth with section caesaria (SC) often experience difficulty to get a 
adequate breast milk production. Various kinds of effort have been conducted to overcome 
this problem, including pharmacological intervention. One of the medicines that could be 
possibly used is domperidon. Domperidon is an antagonist receptor of peripheral dopamine 
that works by choking inhibition effect of prolactin secretion facilitated by dopamine to 
improve breast milk production.The research aimed to unveil the effect of domperidon 
toward breast milk production on mother that give birth with SC in Indonesia. This is a 
quasi-experiment research with two groups post-test only design. The sample of this 
research 30 were post sectio caesarea patients consisting of 15 patients in intervention 
group and 15 patients in control group. Purposive sampling was used in the research 
to get the samples. The instrument used was observation sheets. Result analysis was 
conducted by calculating the frequency distribution and bivariate analysis with Mann 
Whitney test. The average score of breast milk production among post-SC mother in the 
intervention group was 22,60, while the average score of breast milk production among 
post-SC mother in control group was 15,47, Asymp. value Sig (2 tailed) 0,020 (0,020 < 
0,05). Domperidone has been approved to have a significant effect to improve breast milk 
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INTRODUCTION  
Breast milk production is a process of 
releasing oxytocin hormone to floe breast milk 
produced within breast. The problem of early 
releasing breast milk could happen to mothers 
who experience sectio caesaria; it could result in 
bad impact toward the infant because new born 
baby needs colostrum. Post-SC mothers will face 
difficulty in early breastfeeding initiation because 
of rooming-in factor, SC wound, and weakness 
because of anesthesia, therefore post-SC patient 
could do breastfeeding her infant several hours 
after labor (1).
WHO recommends that newborns should 
receive exclusive breastfeeding for six months 
because breast milk is the best natural nutrition 
for babies with the most suitable nutritional 
content for optimal growth (2). UNICEF confirms 
that formula-fed babies have a 25 times higher 
chance of dying in the first month of birth and 
formula-fed babies are 25 times higher than 
babies who are exclusively breastfed (3).
The coverage of exclusive breastfeeding 
in Indonesia is still low, namely 37.3% of babies 
in Indonesia who are exclusively breastfed. It 
means that there are 2/3 of babies in Indonesia 
who are not breastfed exclusively. In Indonesia, 
the number of SC births is high. According to 
national survey data 2018 there were around 
28.9% of all deliveries (4).
Mothers with SC will experience anesthesia 
and postoperative pain so they are not free to 
breastfeed their babies intensely. Besides, after 
surgery mother must be moved to the Recovery 
Room. Although, currently, implementing early 
breastfeeding initiation (IMD) can also be done 
in the operating room, not all hospitals have the 
same policy. In addition, the feeling of the mother 
who is not sure that she can give breast milk to 
her baby because of the condition will cause a 
decrease in oxytocin so the milk cannot come 
out immediately after giving birth and finally the 
mother decides to give formula milk(5).
Domperidone is known to be used as a 
breast milk booster among nursing mothers. IDAI 
stated that domperidone used as a lactogogue 
(a substance that can be trusted to increase 
milk production) was first reported in 1983. This 
substance increases prolactin serum in lactating 
women. Side effects of domperidone are very 
rare, including dry mouth, headache (relieves 
with reduced dose) and stomach cramps. Long-
term high-dose domperidone treatment in mice 
was associated with an increase in the number 
of breast tumors. This has never been reported 
in humans (6).
In Asia and Europe, domperidone has long 
been used as a prokinetics and antiemetic. The 
clinical use of domperidone is in the treatment 
of gastroesophageal reflux disease, diabetic 
gastroparesys, chronic dyspepsia, and is 
sometimes recommended to stimulate post-
partum lactation. Domperidone is the most 
recommended medicine because it has been 
production on post-SC mothers. Improving breast milk production could be conducted 
non-pharmacologically, but pharmacological therapy could also be considered if the non-
pharmacological therapy doesn’t work well in improving breast milk production.
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proven effective, it has no side effects on the baby, 
and rare side effects in breastfeeding mothers. In 
addition, based on the literature, domperidone, as 
a galactogogue, has been widely used in various 
countries even though it is off label ”, such as 
Australia, the Netherlands, Belgium, England, 
Ireland, Italy, Japan and Canada (7).
Domperidone is preferred over other drugs 
to increase milk production because it does not 
cross the blood brain barrier. Domperidone is a 
peripheral dopamine receptor antagonist, works 
by inhibiting the inhibitory effect of dopamine-
mediated prolactin secretion, so that milk 
production increases (8). 
For mothers whose milk production 
decreases and does not respond to non-
pharmacological therapy, the use of galactogogues 
is often considered. Galactogogues are 
substances that are assumed to aid in the 
initiation, continuation or augmentation of breast 
milk production. They include pharmaceutical 
agents and herbal supplements. Recently, the 
Cochrane Collaboration published a review 
of pharmaceutical galactogogues given to 
mothers of hospitalized premature babies. Two 
domperidone trials met the review criteria, and 
the meta-analysis showed modest increases in 
expressed milk volume of 99.49 mL / day (95% 
confidence interval [CI], -1.94-201) in mothers of 
preterm infants who were given domperidone (9).
On a research of cross clinical design 
random double test in Australia toward 6 mothers 
of premature babies that gat domperidon 30 
mg/day and 60 mg/day, 2/3 samples showed 
the improvement of breast milk production and 
significant prolactin serum. The improvement 
of breast milk production among the samples 
is shown on the increase of dosage from 30 
mg became 60 mg, even though the amount of 
domperidon within breast milk is very small and 
the risk toward babies is minimal (6).
Some researchers began to see other benefit 
of domperidone, as galactogogue. The recent 
research proves that the medicine was effective 
to improve breast milk production as the choker 
of dopamine receptor. Besides domperidone, 
there are some medicines that have an effect 
to stimulate lactation (galactogogue), such as 
metoclopramide, chlorpromazine, sulpiride, 
oxytocin hormone and growth hormone (10).
Harapan Jayakarta Hospital is a type C 
hospital that accept reference from private 
midwifery clinic to do sectio caesaria SC based 
one medical indication, in 2018 the number of 
SC was 125 cases, on average 10-12 cases per 
month; from the previous studies conducted by 
a researchers toward 10 post-SC mothers, 5 of 
them don’t produce and release breast milk on 
the third day of the birth. Thus, the researchers 
were interested to do a research entitled “The 
Effect of Domperidone toward Breast Milk 
Production on Post-SC mother in Harapan 
Jayakarta Hospital Jakarta. 
MATERIALS AND METHODS  
This research is a quasi-experimental 
using two group post-test only design. The 
design of this research used two subjects, 
intervention group and control group. The 
intervention group as a group of post-SC mother 
that consume domperidone tablet 10 mg 3 
times for 5 day’s , while control group do not 
consume domperidone. The samples taken for 
this research were 30 post-SC mothers using 
purposive sampling. The inclusion criteria of the 
research were post-SC mother day 1 to 5 day, 
having no allergic history with domperidone and 
willing to be respondents. The research was 
conducted in Harapan Jayakarta Hospital from 
April to June 2019. The independent variable of 
the research is the treatment of Domperidone 
while the dependent variable is breast milk 
production. The instruments of this research 
was observation sheet and electric pump to 
store breast milk among post-SC mother on 
intervention group and control group. Before 
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the treatment explanation was given to the 
respondents through informed consent.
This research has got a permission 
from Harapan Jayakarta Hospital, a letter 
No. 003/ADSDM/RSHJ/III/2019. Data that 
have been collected were processed through 
editing, coding, processing and cleaning. The 
normality test used Shapiro Wilk method (a 
low number of sample ≤ 30 samples). It is 
found the significance result in intervention 
group 0,000 and in control group 0,000. The 
significance value is <0,05 which means that 
the data of breast milk production were not 
distributed normally. Because the data were 
not distributed normally the test that would be 
conducted was non-parametric test. Univariate 
analysis was done to see the distribution of 
the characteristics of pos-SC mothers such 
as, age, education, parity, and occupation. 
Numeric data, age, were presented in the form 
of central tendency distribution Mean, median, 
minimum and maximum value. Categorical 
data were presented by calculating frequency 
distribution and percentage. Bivariate analysis 
was conducted toward two variables to unveil 
the relation between domperidone and breast 
milk production. Test used in the research was 
Mann Whitney test and Rank Spearman test.
RESULT AND DISCUSSION 
Based on Table 1, it shows that from 
15 respondents of post-SC mothers in the 
intervention group, the mean of breast milk 
production is 22,60 with deviation standard 6,905; 
the minimal amount is 7 mL and the maximal 
amount is 32 mL. From the interval estimation, 
it could be concluded that 95% is convinced that 
the breast milk production is between 18,78– 
26,42. While from 15 respondents of post-SC 
mothers on the control group, the mean of breast 
milk production is 15,47, with deviation standard 
8,855; the minimal amount is 2 mL and the 
maximal amount is 30 mL. From the estimation 
of the interval, it could be concluded that 95% 
is convinced that the breast milk production is 
between 10,56 – 20,37.
Based on Table 2, the result of Mann 
Whitney test shows that the rank of breast milk 
production average on the intervention group is 
19,00 and on the control group is 12,00. There is 
difference of average rank between intervention 
and control group. The value of Asymp. Sig. 
(2-tailed) is 0,029 (0,029 < 0,05). It proves that 
the difference of the average rank between the 
two groups means statistically or significantly.
Table 2. Difference Test of Breast Milk production 










Based on Table 3,.it is known that the value of 
Sig. (2-tailed) is 0,020 (0,020 < 0,05). Therefore,it 
could be interpreted that domperidone has a 
convincing effect toward breast milk production. 
The score or the value of correlation coefficient 
is 0,422. This score is within the correlation 
strength score (0,40-0,599); it means that the 
level of correlation strength between domperidone 
variabke and breast milk variable is modest.
Table 3. Domperidone Effect Test toward Breast Milk 
Production on Post-SC Mothers between Intervention 




Breast Milk Production 0,422* 0,020
Table 1. the average of breast milk production on 
Post SC mother Intervention and Control group in 
Harapan Jayakarta Hospital 2019
Breast milk 




Group 15 22,60 6,905 7–32 18,78 – 26,42
Control 
Group 15 15,47 8,855 2-30 10,56 – 20,37
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The research showed that there is a 
significant difference between a group of post-
SC mother who consume domperidone and a 
group of post-SC mothers who do not cosume 
domperidone as can be seen in table 1. The pain 
after SC will choke breast milk production. Beside 
the infant will be sleepy and less responsive 
to breastfeed, especially on the mother who 
consume painkiller before SC (5).
Consuming domperidone is not only effective 
as prokinetic and antiemetic, but also beneficial 
to improve breast milk production among nursing 
mother. On the lactation process hipotalamus 
releases prolactin-inhibiting hormone (PIH) 
which is known as neurotransmitter dopamine 
and prolactin-releasing hormone (PRH). The 
secretion of both hormones influences the 
secretion of prolactin. Domperidone works as 
antagonist receptor of dopamine. The resistance 
of neurotransmitter dopamine in the brain could 
suppress to decrease the PIH production and to 
increase prolactin hormone. It give positive effect 
toward the improvement of the secretion of epitel 
cell alveolar, and stimulate the improvement of 
breast milk secretion (7).
To value the breast milk production in this 
research used observation sheet such as the 
amount of breast milk pumped using electric 
pump and the consistence of breast, milk that 
came out from the nipple if it is pressed using 
hand, the frequency of urinating of the baby 
6-8 times a day, sleep/quite after breastfeed, 
secreting meconium within 24 hours.
The result of this research is in line with 
a research conducted by Campbell-Yeo, et al 
(2010), the volume of breast milk consuming 
domperidon improves up to 26,7% compared 
to placebo group that only improves 18,5% 
(p=0,005). The signifin=cant improvement of 
breast milk production statistically after the 
domperidone treatment is 74,72% (95% CI 
= 54,57; 94,86, P <0,00001) in daily breast 
milk production  with domperidone treatment 
compared to placebo (6).
Then, the table shows that the level of 
correlation strength between domperidone 
variabel and breast milk variable is modest 
or medium; it is in-line with the research by 
Campbell-Yeo, et al (2010), the volume of breast 
milk of nursing mother consuming  domperidon 
improve up to 26,7% compared to placebo group 
that only improve 18,5% (p=0,005).
In accordance with research conducted 
previously that consuming Domperidone 60 mg/
day for 14 days improve the breast milk volume 
as 367% compared to 30 mg/day that only 
improves 215%(9).
There are some factors that cause the breast 
milk production decreases in the intervention 
group such as IMD, physical condition of mother/
infant, so room in and breast milk on demand 
could not be done. A number of researches have 
stated that Nullipara mother will result in higher 
prolactin serum compared to multipara in the 
same dosage of medicine. However, the volume 
of breast milk produced by multipara is still higher 
that nullipara (8). The limitation of the research is 
that the subject of the research is less in number 
and the researchers did not observe the prolactin 
serum in every sample being observed. 
CONCLUSION AND RECOMENDATIONS
There is a significant correlation between 
domperidone variable and breast milk production 
with the correlation strength level between 
domperidone and breast milk production 
is medium. We have to support exclusive 
breastfeeding by giving motivation, health 
education, avoiding stress for nursing mother. 
It is as a consideration to have collaboration to 
have pharmacological therapy (Domperidon) in 
order that mother could breastfeed her infant to 
improve psychological relationship and infant 
growth.
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